Daligdig, Mae Ann .

HRN: 28-77-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
AMPICILLIN 1GM (VIAL)
04/04/2026
04/06/2026
IVT
2g
Q6
Prom
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: